RITEZONE.NS,0P0001PYLL,0
RITEZONE · General/Diversified · NSE
₹39
Current Market Price
Fair Value (DCF)
₹35
Margin of Safety
-9.2%
Updated 10h ago
YieldIQ Score
47/100
Piotroski F-Score
2/9
Economic Moat
Narrow
Confidence
34%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹16 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
1.22×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹39
Bear case
₹22.17
MoS -75.9%
Base case
₹35.42
MoS -10.1%
Bull case
₹43.63
MoS +10.6%
Ratio Trends
Historical ratio trends for RITEZONE are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.
Historical Financials
Historical financials for RITEZONE are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.
Peer Comparison
Peers not yet ranked for RITEZONE. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
No dividend events recorded for RITEZONE in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. RITEZONE.NS,0P0001PYLL,0 (RITEZONE.NS) trades at 39.00 vs a model fair value of 35.42, a gap of -9.2%. Piotroski F-score: 2/9. Moat label...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of RITEZONE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for RITEZONE →
Compare
Head-to-head with peers
Compare RITEZONE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse RITEZONENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.